| Previous Section | Index | Home Page |
21 Feb 2008 : Column 954W—continued
Sandra Gidley: To ask the Secretary of State for Health (1) how many women (a) under 25, (b) 25 to 35, (c) 35 to 50, (d) 50 to 60 and (e) over 60 years of age had a CIN 3 graded smear test in each of the last five years for which figures are available; [183761]
(2) how many women under the age of 25 years had a smear test with a CIN 3 result in each of the last five years for which figures are available. [186872]
Ann Keen: Data for CIN3 are aggregated by age and with data for adenocarcinoma, we are not able to spilt them up. The following tables give figures, for the last five years, for women, whose cervical test outcome was CIN 3 and adenocarcinoma.
| Women (all ages) where outcome was CIN3 and adenocarcinoma in situ following referral after persistent non-negative sample (low grade— i.e. category 1/8/3 result) for 2001-02 to 2005-06 and April to June 2006 | |
| England | Number |
| Women (all ages) where outcome was CIN3 and adenocarcinoma in situ following referral after single occurrence of potentially significant abnormality (high grade i.e. category 7/4/5/6 result) for 2001-02 to 2005-06 and April to June 2006 | |
| England | Number |
| Notes: 1. Data for outcome of referrals is a retrospective collection and annual data for this dataset is always a year behind the rest of the published data for cervical screening, however the first quarter for the following year is available and published at the same time, this has been provided for the period April to June 2006 to show the most up to date information available. 2. Figures for 2005-06 and April to June 2006 differ slightly from those published. Arrowe Park Hospital’s laboratory data was submitted with the quarter and the annual data the wrong way round. 3. The latest data on cervical screening is available in the Information Centre’s publication “Cervical Screening Programme, England 2006-07”. 4. Low grade includes the results; inadequate (cat 1), borderline (cat 8) and mild dyskaryosis (cat 3) High grade includes the results; moderate dyskaryosis (cat 7), severe dyskariosis (cat 4), severe dyskariosis/?invasive carcinoma (cat 5) and ?glandular neoplasia (cat 6) 5. CIN (cervical intra-epithelial neoplasia) is an indicator of the depth of abnormal cells within the cervix CIN3 is where the full thickness of the surface layer is affected (also known as carcinoma in situ) Source: The Information Centre for Health and Social Care Form KC61 part C1 and C2 | |
Clinical Negligence
Mr. Lansley: To ask the Secretary of State for Health pursuant to the answer of 24 January 2008, Official Report, column 2238W, on clinical negligence, by how much the forecast value of claims in the future has required amendment; and for what reason. [184500]
Ann Keen: This information could be obtained only at disproportionate cost.
The reasons for change in value of future claims settlements can vary from changed information on the specific damage caused to changes in the interpretation of case law and its impact on future settlements. The NHS Litigation Authority (NHSLA) carry out a rigorous review at least twice per annum of all of our models which forecast claims not yet received and keep a constant review of all ‘known claims’ throughout their life. NHSLA’s systems and processes are audited by the National Audit Office who have yet to offer any concern in relation to NHSLA’s accounting treatment or indeed the quality of advice they are purchasing from either legal or actuarial professionals.
Mr. Lansley:
To ask the Secretary of State for Health pursuant to the answer of 24 January 2008, Official Report, column 2238W on clinical negligence, how many claims under the Clinical Negligence Scheme for
Trusts there have been relating to care or treatment for cancer since 1995; and what the value has been of such claims. [184501]
Ann Keen: The following table shows the information requested.
| Speciality | Number of claims | Outstanding estimate (£) | Total paid (£) | Total claim (£) |
Community Care
Norman Lamb: To ask the Secretary of State for Health how many people and what proportion of the population received continuing healthcare in each primary care trust area in England in each of the last five years. [183767]
Mr. Ivan Lewis: The information requested has been placed in the Library.
Diabetes: Medical Equipment
Sandra Gidley: To ask the Secretary of State for Health what advice has been issued to general practitioners on the prescription to diabetics of blood-testing strips. [183907]
Ann Keen: In September 2002, the National Institute for Health and Clinical Excellence (NICE) issued clinical guidelines on Management of Type 2 Diabetes—Managing Blood Glucose. The guidelines include advice on the self-monitoring of blood glucose, and state that although self-monitoring can have benefits, it should only be carried out as part of an integrated self-care package and if the purpose is clear and agreed with the patient.
The guidelines are under review and will be reissued as part of the Type 2 diabetes: the management of type two diabetes (update), expected to be published by NICE in April 2008.
In July 2004 NICE issued clinical guidelines on Type 1 diabetes: diagnosis and management of Type one diabetes in children, young people and adults. These guidelines also state that self-monitoring of blood glucose levels should be used as part of an integrated package to help choice and achieve the best outcomes.
A statement on blood glucose self-monitoring was reissued in February 2005 via the Medical Director, Chief Nursing Officer and general practitioner bulletins to reinforce the message that self-monitoring may prove useful to people in their overall approach to self-care.
Diabetes: Screening
Mr. Lansley: To ask the Secretary of State for Health how many people (a) were offered and (b) accepted screening for diabetic retinopathy in each year since 2003-04. [184560]
Ann Keen: The following tables show the number of people with diabetes offered screening for diabetic retinopathy and the number of people receiving screening broken down by year.
| Number of people with diabetes offered screening for diabetic retinopathy( 1) | |
| Number of people with diabetes receiving screening for diabetic retinopathy( 1) | |
| (1) Data from Local Delivery Plans returns. (2) Data for year 2003-04 was an incomplete return. | |
Doctors: EU Nationals
Peter Bottomley: To ask the Secretary of State for Health what information his Department holds on which European countries’ doctors in the UK (a) have come from and (b) are likely to come from in the future, based on current staffing and future projections, as a result of the EU Professional Qualifications Directive for Health Professionals. [186640]
Ann Keen: The European countries that doctors come from is not collected centrally. The NHS Workforce Census does collect the countries where doctors qualified. Such information as is available is shown in the following table.
The European Union Professional Qualifications Directive may have an impact of the future flows from European countries because the directive is about freeing up professional mobility. The flow of doctors will continue to depend upon the requirements of employing organisations and the competitiveness of doctors applying for employment.
Ear Nose and Throat: Surgery
Tim Loughton: To ask the Secretary of State for Health how many (a) adult and (b) child tonsillectomies were carried out in each of the last five years. [186742]
Ann Keen: The numbers of finished admission episodes where the primary or secondary operative procedure was a tonsillectomy for people aged (a) under 18 and (b) 18 and over in each of the last five years is set out in the following table.
| Next Section | Index | Home Page |